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Identifying Novel Regulators of Necroptosis
Vinay Penna
Mentors: Wayne Yokoyama and Swapneel Patel
Necrosis had long been considered a form of dysregulated cell death caused by disease.
Recent evidence has revealed that some forms of necrosis have defined molecular
pathways. Necroptosis is the most studied of these pathways and involves receptor
interacting protein kinase 3 (RIPK3). Necroptosis has been implicated in a variety of
diseases including inflammatory bowel diseases, pancreatitis, and ischemia-reperfusion
injury. Despite its suspected involvement in these maladies, little is known about the
molecular pathway of necroptosis as only a few key proteins have been identified. We
hypothesize that there are other genes involved in this process which have yet to be
associated with necroptosis as other cell death pathways have many more molecular
players.  In order to discover novel regulators of this pathway we conducted a broad
genetic screen, using a genome wide CRISPR/Cas9 library to search for genes whose
loss led to resistance to necroptosis. We packaged the CRISPR/Cas9 machinery into a
lentiviral delivery system, which was used to infect mouse embryonic fibroblasts
(MEFs). The infected cells are subject to either control stimulus or necroptopic
stimulus. Virtually all of the wild-type cells died when subject to necroptosis. Surviving
cells likely have a resistance phenotype generated by the loss of key genes. Treated and
control groups were then analyzed via PCR amplification and deep sequencing.
Subsequent computational analysis of the sequencing results provided a list of genes
with potential involvement in necroptosis, including those already implicated in the
pathway such as RIPK1, RIPK3, MLKL, CYLD, and TNFRSF1A. We then selected a
number of candidate genes and subjected them to further molecular analysis. We believe
that this CRISPR/Cas9 based screening strategy will be a powerful tool for identifying
novel regulators of necroptosis.
